Skip to main content

Ikarian Capital, LLC

Position in CMPX — Compass Therapeutics, Inc.

CIK 1778253 DALLAS, TX

Position in CMPX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$39,420
-$55,800 QoQ
Shares Held
18,000
0.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#150
of 213 holders
Holding Since
Dec 2021
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CMPX Over Time

Shares Held

Position Value (USD)

Derivatives in CMPX

reported options exposure · as of Mar 31, 2025
CallValue
$1,258,180
CallShares
662,200
PutValue
$1,258,180
PutShares
662,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names. CMPX ranks #101 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CMPX

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $39,420 18,000
2026-03-31 $95,220 18,000
2025-12-31 $4,296,000 800,000
2025-03-31 $1,258,180 662,200
2025-03-31 $1,258,180 662,200
2022-03-31 $101,614 74,171
2021-12-31 $221,900 70,000